[go: up one dir, main page]

GB201916239D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB201916239D0
GB201916239D0 GBGB1916239.5A GB201916239A GB201916239D0 GB 201916239 D0 GB201916239 D0 GB 201916239D0 GB 201916239 A GB201916239 A GB 201916239A GB 201916239 D0 GB201916239 D0 GB 201916239D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1916239.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inflazome Ltd
Original Assignee
Inflazome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inflazome Ltd filed Critical Inflazome Ltd
Priority to GBGB1916239.5A priority Critical patent/GB201916239D0/en
Publication of GB201916239D0 publication Critical patent/GB201916239D0/en
Priority to PCT/EP2020/081288 priority patent/WO2021089781A1/en
Ceased legal-status Critical Current

Links

GBGB1916239.5A 2019-11-07 2019-11-07 Novel treatment Ceased GB201916239D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1916239.5A GB201916239D0 (en) 2019-11-07 2019-11-07 Novel treatment
PCT/EP2020/081288 WO2021089781A1 (en) 2019-11-07 2020-11-06 Treatment or prevention of psychiatric brain disorders using the nlrp3 inhibitor n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1 -isopropyl-1 h-pyrazole-3-sulfonamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1916239.5A GB201916239D0 (en) 2019-11-07 2019-11-07 Novel treatment

Publications (1)

Publication Number Publication Date
GB201916239D0 true GB201916239D0 (en) 2019-12-25

Family

ID=69062292

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1916239.5A Ceased GB201916239D0 (en) 2019-11-07 2019-11-07 Novel treatment

Country Status (1)

Country Link
GB (1) GB201916239D0 (en)

Similar Documents

Publication Publication Date Title
GB201916237D0 (en) Novel treatment
GB201813876D0 (en) Treatment
GB201800274D0 (en) Novel treatments
GB201900702D0 (en) Therapy
IL288937A (en) Improved treatment using eyp001
GB201800546D0 (en) Treatment
GB201913988D0 (en) Novel treatment
SG11202102827YA (en) Treatment methods
SG11202102878TA (en) Treatment methods
GB201914296D0 (en) Treatment
GB201912365D0 (en) Treatment
GB201916754D0 (en) Novel treatment
GB201916234D0 (en) Novel treatment
GB201916239D0 (en) Novel treatment
GB201916238D0 (en) Novel treatment
GB201916235D0 (en) Novel treatment
GB201916236D0 (en) Novel treatment
GB201912760D0 (en) Treatment
GB201912335D0 (en) Treatment
GB201911816D0 (en) Treatment
GB201911603D0 (en) Treatment
GB201910755D0 (en) Treatment
GB201904253D0 (en) Treatment
GB201902579D0 (en) Treatment
GB201902578D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)